Literature DB >> 24393054

Stereotactic radiosurgery and fracture fixation in 6 dogs with appendicular osteosarcoma.

Jennifer L Covey1, James P Farese, Nicholas J Bacon, Sandra P Schallberger, Pierre Amsellem, Ryan P Cavanaugh, Rowan J Milner.   

Abstract

OBJECTIVE: To evaluate clinical outcome of dogs with appendicular osteosarcoma (OSA) treated with stereotactic radiosurgery (SRS) and subsequent internal fixation of a pathologic fracture. STUDY
DESIGN: Retrospective case series. ANIMALS: Dogs with spontaneous-occurring appendicular OSA (n = 6).
METHODS: Medical records (May 2002-January 2008) of dogs that had SRS for appendicular OSA were reviewed. Dogs were included if they had a pathologic fracture either before or after SRS and were treated with internal fixation. Signalment, history, physical examination findings, clinicopathologic data, diagnostic imaging findings, biopsy results, surgical complications, number of surgeries, adjuvant therapy, development of metastatic disease and cause of death were recorded.
RESULTS: Six dogs met the inclusion criteria. Two dogs had a pathologic fracture at admission and 4 dogs developed a fracture after SRS with a mean ± SD time to fracture development of 6.25 ± 1.65 months. The first 3 fractures were repaired using an open approach and the latter three using minimally invasive percutaneous osteosynthesis (MIPO). Infection occurred in 5 dogs and implant failure in 3. Limb function was subjectively assessed as good in all dogs when the implants were stable and infections were subclinical. Survival times ranged from 364-897 days; 1 dog was lost to follow-up.
CONCLUSIONS: Fracture repair using internal fixation should be considered a viable limb-sparing alternative for pathologic fractures that have been treated with SRS. © Copyright 2014 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2014        PMID: 24393054     DOI: 10.1111/j.1532-950X.2014.12082.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  8 in total

Review 1.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  Image-guided stereotactic radiotherapy in 4 dogs with intracranial neoplasia.

Authors:  Alaina Burkard Moon; Heidi Barnes Heller; Lisa Forrest
Journal:  Can Vet J       Date:  2016-05       Impact factor: 1.008

3.  Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.

Authors:  Christiane Gebhard; Andrea Fuchs-Baumgartinger; Ebrahim Razzazi-Fazeli; Ingrid Miller; Ingrid Walter
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

4.  Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs.

Authors:  Tiffany Wormhoudt Martin; Lynn Griffin; James Custis; Stewart D Ryan; Mary Lafferty; Mary-Keara Boss; Daniel Regan; Sangeeta Rao; Del Leary; Stephen J Withrow; Susan M LaRue
Journal:  Vet Comp Oncol       Date:  2021-01-13       Impact factor: 2.385

Review 5.  What do we know about canine osteosarcoma treatment? Review.

Authors:  M Szewczyk; R Lechowski; K Zabielska
Journal:  Vet Res Commun       Date:  2014-11-26       Impact factor: 2.459

6.  Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.

Authors:  Lynn R Griffin; Douglas H Thamm; Ariel Brody; Laura E Selmic
Journal:  J Vet Intern Med       Date:  2019-02-15       Impact factor: 3.333

Review 7.  Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.

Authors:  Timothy M Fan; Kimberly A Selting
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

8.  Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.

Authors:  Jonathan Mackowiak da Fonseca; Ivone Izabel Mackowiak da Fonseca; Marcia Kazumi Nagamine; Cristina de Oliveira Massoco; Adriana Tomoko Nishiya; Jerrold Michael Ward; Shihui Liu; Stephen Howard Leppla; Thomas Henrik Bugge; Maria Lucia Zaidan Dagli
Journal:  Toxins (Basel)       Date:  2020-09-24       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.